A股異動 | 海南發展(002163.SZ)大漲逾8% 擬1350萬元以非公開協議方式受讓免税品集團45%股權
格隆匯1月25日丨海南發展(002163.SZ)大漲逾8%,報21.35元,總市值171.56億元。海南發展上週五公佈,為了推進公司戰略轉型,擴展業務領域,培育新型產業資源,公司擬以非公開協議轉讓方式受讓海南海控免税品集團有限公司(“免税品集團”)45%股權。公司將與全球消費精品(海南)貿易有限公司就以上股權轉讓事項簽訂《股權轉讓協議》。股權轉讓價格依據免税品集團經國資有權部門備案後的淨資產評估值3000萬元作為定價依據,免税品集團45%股權對應股權轉讓價格為1350萬元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.